Short-end injection combined with sweeping-FASS MEKC was a new CE method for determination of deferasirox in plasma.
The established CE method was applied for determination of deferasirox in five clinical β-thalassemia patients.
Separation time of deferasirox by the CE method was within 3.5 min.